Skip to main content
. 2016 Jul 27;8(8):452. doi: 10.3390/nu8080452

Figure 1.

Figure 1

Overview of the trial period. CAS, casein; PLA, placebo. Each sample collection marker (•) indicates the dialysate vial number and the time when the vials were attached to the exit end of each probe (i.e., vial 1 was worn immediately post-equilibration for 30 min). Dialysate samples of interest were the overnight and immediate next morning samples (markers 3 and 4).